Search

everythinglearnresearchcommunity

for

Search:↓

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Possible link between androgens and COVID-19 severity; more research needed.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Clascoterone is safe for the heart, even at high doses.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

A 12-year-old girl with very high testosterone and insulin resistance improved with birth control pills, suggesting PCOS can cause high testosterone without tumors.

PCOS is linked to low-grade chronic inflammation.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

A 9-year-old girl developed type 1 diabetes and alopecia after being treated for a rare kidney disease.

Thyroid function may influence hair loss after COVID-19.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Insulin resistance linked to obesity may increase COVID-19 severity.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.